, or equivalent experience Req IQVIA is a leading global provider of clinicalresearch services, commercial insights.... Provides peer support and helps on-board new Associate Software Engineers to the team. Typically requires 2 years of prior...
global provider of clinicalresearch services, commercial insights and healthcare intelligence to the life sciences... based on frequently asked questions or revised policies/procedures. Qualifications Associate's Degree Req 2 years HRIS...
Overview As a Senior Clinical Data Science Lead you will be joining the world’s largest & most comprehensive clinical... research organisation, powered by healthcare intelligence. Immediate Joiner Required Officebased - Bangalore/Chennai...
responsibilities covered in the job description for Scientific Communications Associate; the percentage contribution of these..., medical affairs, clinical development, health outcomes, public health, scientific or medical communications field. Expertise...
are determined to make life better for people around the world. Organization Overview: The purpose of the Associate, GSC Clinical... Trial Registry Writing is to support the development and implementation of Clinical Trial Registry (CTR) systems...
Role: The individual is responsible for providing clinical expertise and support to the health insurance business... in Asia, and ideally, another region (Europe, Middle East, Americas). The Consultant will work closely with clinical...
Job Description Associate Specialist- Global Commercial Pharma Pipeline Analytics Our Human Health Digital Data... the impact. The Associate Specialist, Global Commercial Pharma Pipeline Analytics, HHDDA will be responsible...
information, be it scientific, clinical, commercial, corporate or regulatory Primary Research: Collect market, competitor...Associate Consultant - Contractua in Life Science consulting (3 months), Competitive Strategy India - Gurugram...
Job title: Sr. Associate – HEVA (Evidence Synthesis) Hiring Manager: Head/Group Lead/Research Lead/Team Lead HEVA... research studies to support the clinical, economic and humanistic value of products; Studies include but are not limited...
intelligence and clinicalresearch organization. We’re proud to foster an inclusive environment driving innovation and excellence... Management side of our Contracts team within the ClinicalResearch Industry. Do you have an interest in negotiation, Contracting...
Thousands rally against the arrest of opposition politician Ekrem Imamoglu, but his party says their planned protests are coming to an end. Continue Reading »
Zerodha has introduced six new features to its Kite trading platform, aiming to enhance the order placement experience. Founder and CEO Nithin Kamath shared updates on enhancements like order slicing and available margin on social media. Continue Reading »
Looking at the history, the Nifty50 has undergone corrections annually, with declines varying from around 4 per cent to as much as 60 per cent. Continue Reading »
Expert view on markets: Chandraprakash Padiyar from Tata Asset Management is optimistic about India's earnings revival, expecting Q4FY25 to outperform Q3FY25. In an interview with Mint, he highlights strong domestic demand and risks from US tariffs. Continue Reading »
Shri Ahimsa Naturals IPO opened for subscription on March 25 and closes on March 27, with a price band of ₹113 to ₹119 per share. The company specializes in caffeine products and has a manufacturing facility in Jaipur, Rajasthan. Continue Reading »
The Nifty Smallcap 100 index has gained 10% in March after a tough February, with sectors like defense and metals leading recovery. As per analysts, its current P/E ratio of 27.7, although elevated, remains below the 10-year median P/E of 32, suggesting further room for re-rating Continue Reading »
IndusInd Bank share price has plunged 35% in one month and is down 30% on a year-to-date (YTD) basis. Over the past six months, IndusInd Bank shares have dropped 54%, while the banking stock has declined 34% in two years. Continue Reading »
The stock has delivered impressive multibagger returns for long-term investors, soaring by 107.74 per cent over the past five years. Continue Reading »